Hetero gets DGCI approval for generic version of tocilizumab
"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of Tocilizumab," it said in a statement. India has faced a huge shortage of tocilizumab, used to treat critically ill Covid patients-during the Covid surge. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2021 Category: Pharmaceuticals Source Type: news

Kenya: Shortage of Key Drugs Threatens War On Covid-19
[Nation] Kenya's fight against Covid-19 faces a major hurdle after it emerged that key antiviral drugs Remdesivir and Actemra are virtually out of stock. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 20, 2021 Category: African Health Source Type: news

Tocilizumab Shortage Continues as Pandemic Wears On Tocilizumab Shortage Continues as Pandemic Wears On
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory conditions are faring better — for now.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 19, 2021 Category: Rheumatology Tags: Rheumatology News Source Type: news

U.S. Hospitals Are Running Out Of A Crucial Covid Drug Amid Delta Surge And Worldwide Shortages
Hospitals could be without tocilizumab, one of the only therapies for Covid-19 patients cleared for use in the U.S., for weeks and the World Health Organization urged maker Roche to ensure it is distributed fairly around the world. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 18, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Policy /policy Manufacturing /manufacturing Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news

HBV Screen Often Incomplete Before Tocilizumab, Tofacitinib Used HBV Screen Often Incomplete Before Tocilizumab, Tofacitinib Used
About three quarters of patients starting either drug in a single health system did not undergo complete hepatitis B virus screening beforehand.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 10, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Update to living WHO guideline on drugs for covid-19, BMJ (published/updated 6th July 2021)
The WHO have updated their guidance, now recommending IL-6 receptor blockers (tocilizumab and sarilumab) for severe and critical covid-19, on the basis of the RECOVERY and REMAP-CAP trials. They acknowledge potential access issues around IL-6 receptor blockers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 8, 2021 Category: Consumer Health News Source Type: news

Remdesivir, tocilizumab helped patients: Study
Severely ill Covid-19 patients fared better when they received remdesivir and tocilizumab, two experimental drugs given individually or in combination, than those who did not get them, observed doctors from KEM Hospital, a premier medical college and hospital. (Source: The Economic Times)
Source: The Economic Times - July 3, 2021 Category: Consumer Health News Source Type: news

Government plans national stockpile of life-saving drugs to combat third Covid wave
The government is in discussions with the pharma and medical devices industry to create a "national stockpile" of life-saving drugs and vital equipment to combat the third Covid wave. This could prevent the massive shortages of critical drugs like Remdesivir, Tocilizumab, key antibiotics, and devices like oxygenators and pulse oximeters, as witnessed during the brutal second wave with a huge daily case-load. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 29, 2021 Category: Pharmaceuticals Source Type: news

Efficacy and Safety of Tocilizumab in Elderly GCA Patients Efficacy and Safety of Tocilizumab in Elderly GCA Patients
Tocilizumab has recently been approved for the treatment of giant cell arteritis, but what do we know about the safety and efficacy in elderly patients?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2021 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

FDA authorizes rheumatoid arthritis drug for emergency use to treat severely ill COVID-19 patients
Actemra, which is manufactured by Roche, will be given to hospitalized patients who are already receiving steroid drugs, oxygen and other measures to fight the virus. (Source: the Mail online | Health)
Source: the Mail online | Health - June 25, 2021 Category: Consumer Health News Source Type: news

Arthritis Drug Tocilizumab Gets FDA EUA for Severe COVID-19 Arthritis Drug Tocilizumab Gets FDA EUA for Severe COVID-19
For patients hospitalized with COVID-19, tocilizumab plus standard care has been shown to cut the risk for death, shorten hospitalization time, and reduce the need for mechanical ventilation.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 25, 2021 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Arthritis Drug Tocilizumb Gets FDA EUA for Severe COVID-19 Arthritis Drug Tocilizumb Gets FDA EUA for Severe COVID-19
For patients hospitalized with COVID-19, tocilizumab plus standard care has been shown to cut the risk for death, shorten hospitalization time, and reduce the need for mechanical ventilation.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 25, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). (Source: World Pharma News)
Source: World Pharma News - June 25, 2021 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Roche ’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
Basel, 25 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra ® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). The E UA is based on results from four randomised, controlled studies that evaluated Actemra/RoActemra for the treatment of COVID-1...
Source: Roche Investor Update - June 25, 2021 Category: Pharmaceuticals Source Type: news

Roche ’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
Basel, 25 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra ® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric patients (two years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). The E UA is based on results from four randomised, controlled studies that evaluated Actemra/RoActemra for the treatment of COVID-1...
Source: Roche Media News - June 25, 2021 Category: Pharmaceuticals Source Type: news